Brinda Sethugavalar
Leeds Teaching Hospitals NHS Trust
Quality of lifeInternal medicineSexual functionBrachytherapyLongitudinal studyProstate brachytherapyProstate cancerImplantMedicineUrinary system
Publications 1
Purpose This prospective longitudinal study quantifies health-related quality of life (HRQoL) up to 10 years following permanent iodine-125 (125I) prostate brachytherapy alone for localized prostate cancer. Material and methods In total, 120 patients completed a validated expanded prostate cancer index composite (EPIC) questionnaire pre-treatment and at 8 time points after treatment (6 weeks, 6, 10, 18 months, and 2, 3, 5, 10 years). At each time point, clinically relevant small, moderate, and s...